Replies to post #117811 on Anavex Life Sciences Corp (AVXL)

[Reyeton]

My suspicion has to do with biogen's involvement with Anavex-273. They have our product for months with no movement foward. I am sure they are well versed in our IP protection. It would not surpriise me if they are lying in wait hoping our IP patent will be denied so they can swoop in and grab it up. More is resting on our patent approval than meets the eye. I see limited to no chance of partnering with biogen. Once we have the patent in hand, I believe we will see great change in how Dr Missling handles information. Seems we are being held in place by biogen. All my opinion.

[nidan7500]

bear...AGAIN, I find myself agreeing with your rationale and other thoughts on why we are where we are. It's the WHAT'S NEXT part that has us hanging by our fingertips.

We are looking at a potential binary event, no going back if A2-73 continues to perform. The platform science has been explained, the trial results have been published, plans have been carefully defined, resources seem to be lined up. It is a ONE or a ZERO, with evidence pointing to a massive win.

BTW, I also thought we stayed out of AAIC b/c with new FDA protocols being announced the context for any plans would be mixed at best. We cannot discuss what happens next until FDA defines new protocols.

[baltimorebullet]

Then why loan it to Biogen?